Initial studies demonstrated a relationship between baseline IgE levels and the dose required to decrease IgE below 50 ng/mL and between baseline IgE level, dose, and activity in allergic rhinitis [10,11]. This evidence concerns the gene IGHE and allergic rhinitis.